Businesses in the UK need to move beyond tinkering with artificial intelligence (AI) and get on with seriously harnessing the technology at scale to compete on the global stage, a report by Microsoft has said.
Artificial intelligence could be used to help prevent traffic jams months before they have time to appear, new Government plans have revealed.
A Dundee firm which is a world leader in the use of artificial intelligence (AI) to aid drug discovery will focus on finding cures for rare diseases with its latest pharma partnership.
A new exhibition will open at the Barbican Centre in London tomorrow. ‘AI: More Than Human’ explores the relationship between humans and artificial intelligence through scientific and creative developments.
A Dundee life sciences firm could be valued at more than £1 billion if it lists on the stock exchange, a financial analyst has claimed.
Dundee life sciences company Exscientia has set its sights on becoming the “dominant player” in the use of artificial intelligence to discover new drugs after a $26 million cash injection.
Vision of the future: How Robots exhibition at National Museum of Scotland puts the ‘human’ into humanoid
As a major Robots exhibition comes to the National Museum of Scotland in Edinburgh, Michael Alexander glimpses the future and discovers that so much of robotics is dependent on an understanding of humanity.
The benefits of artificial intelligence (AI) are evident, but is it also a threat to the very existence of humanity? Michael Alexander sought the opinions of experts.
With campaigning for the UK general election in full swing, and Brexit appearing to be the dominant issue for the parties and the media, a survey by two global business futurists has suggested that respondents want to look further ahead by focusing on a progressive reform agenda that positions the UK as a major player on the global stage over the next five years.
A Dundee University spin-out company has secured a potential €250 million pipeline of work after agreeing a deal with life sciences giant Sanofi.